Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guben Kechuan granules for chronic bronchitis
ChiCTR2200063321Phase 4Not yet recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Guben Kechuan in chronic bronchitis (CB) (3 arms), sponsored by China-Japan Friendship Hospital. Primary endpoints: Symptom evaluation of chronic bronchitis (cough, expectoration, wheezing), Acute exacerbation of chronic bronchitis (AECB) and 4 more. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
Guben Kechuan
03
Conditions
chronic bronchitis (CB)
Beyond the preview
Go deeper on ChiCTR2200063321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063321.